TOP STORIES

• ACADEMIA University’s Seriousness to Unravel Diovan Saga Called into Question
  July 17, 2013

• REGULATORY 2nd Committee on Drugs to Discuss Approval for Asthma Treatment Flutiform on July 26
  July 17, 2013

• REGULATORY MHLW, US FDA to Exchange Information with a View to Standardizing Review Guidelines for Regenerative Medicines
  July 17, 2013

• REGULATORY Health Ministry to Set Up Committee on Diovan Studies, Compile Preventive Measures for Clinical Data Manipulation
  July 16, 2013

• REGULATORY MHLW Presses Kyoto Prefectural University of Medicine to Carry on Diovan Probe
  July 16, 2013

• ACADEMIA “Data Manipulated” in KYOTO Heart Study: Univ. Probe
  July 12, 2013

• ORGANIZATION JPWA Sets Up New Committee on Consumption Tax, NHI Drug Pricing Issues
  July 12, 2013

• BUSINESS Drug Makers to Disclose Payment Information This Summer Based on Transparency Guidelines
  July 11, 2013

• BUSINESS Blood Derivative Titan CSL Set to Beef Up Japan Biz with New Products
  July 10, 2013

• REGULATORY TPP Member States to Brief Japan on Drug Pricing, Intellectual Property on July 25
  July 9, 2013

• ORGANIZATION JSGM Officially Announces Unified Brand Name Plan for Generic Combination Drugs; 1st Single Name to Be Given to Preminent
  July 8, 2013

• ORGANIZATION JSGM Working to Build Consensus on Unified Brand Names for Generic Combination Drugs
  July 5, 2013

• ACADEMIA “No Data Manipulation” in VART Study of Diovan: Interim Report of Japanese Society of Hypertension
  July 4, 2013

• REGULATORY Notification Calls for Simultaneous Filing of Applications for Companion Diagnostics and Drugs
  July 3, 2013

• BUSINESS Japanese Society of Chemotherapy Joins Hands with Pharmas, Govt to Spur New Antibiotic Development
  July 2, 2013

• ORGANIZATION JMA Sets Up Pharmaceutical Affairs Section
  July 1, 2013

• BUSINESS Bayer Yakuhin to Shift Resources to Innovative New Drugs: President Brunn
  June 28, 2013

• ACADEMIA NHO Attains 30% Volume-Based Generic Target in FY2012
  June 28, 2013

• REGULATORY MHLW Maps Out New Vision for Pharma Industry; Research-Based Makers Will See “Survival of the Fittest,” It Says
  June 27, 2013

• BUSINESS Eisai to Suspend Sales of Future Mainstay Antiepileptic Drug in Germany
  June 26, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 216
• 217
• 218
• 219
• 220
• 221
• 222
• 223
• 224
• …
• Next ›
• 最終 »